Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Jankovic J, Rivera VM. Hereditary myoclonus and progressive distal muscular atrophy. Ann Neurol. 1979;6:227–31.
Zhou J, Tawk M, Tiziano FD, Veillet J, Bayes M, Nolent F, et al. Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1. Am J Hum Genet. 2012;91:5–14.
Dyment DA, Sell E, Vanstone MR, Smith AC, Garandeau D, Garcia V, et al. Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy. Clin Genet. 2014;86:255–563.
Gan JJ, Garcia V, Tian J, Tagliati M, Parisi JE, Chung JM, et al. Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy. Neuromuscul Disord. 2015;25:959–63.
Rubboli G, Veggiotti P, Pini A, Berardinelli A, Cantalupo G, Bertini E et al. Spinal muscular atrophy associated with progressive myoclonic epilepsy: a rare condition caused by mutations in ASAH1. Epilepsia. 2015;56:692–8.
Teoh HL, Solyom A, Schuchman EH, Mowat D, Roscioli T, Farrar M, et al. Polyarticular arthritis and spinal muscular atrophy in acid ceramidase deficiency. Pediatrics. 2016;138:e20161068.
Kernohan KD, Frésard L, Zappala Z, Hartley T, Smith KS, Wagner J, et al. Whole-transcriptome sequencing in blood provides a diagnosis of spinal muscular atrophy with progressive myoclonic epilepsy. Hum Mut. 2017;38:611–4.
Topaloglu H, Melki J. Spinal muscular atrophy associated with progressive myoclonus epilepsy. Epileptic Disord. 2016;18:S128–34.
Schuchman EH. Acid ceramidase and the treatment of ceramide diseases: the expanding role of enzyme replacement therapy. Biochim Biophys Acta. 2016;1862:1459–71.
Filosto M, Aureli M, Castelotti B, Rinaldi F, Schiumarini D, Valsecchi M, et al. ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: a clinical, biochemical and molecular study. Eur J Hum Genet. 2016;24:1578–83.
Acknowledgements
NAMEvdB received a grant from the Prinses Beatrix Spierfonds. Exome sequencing took place as part of the “Myocapture sequencing project”, financed through the France Génomique National infrastructure (“Investissements d’Avenir” program ANR-10-INBS-09) and the Fondation Maladies Rares.
Authors contributions
NAMEvdB analysis and interpretation of data, drafting of manuscript. IN acquisition of data, critical revision of manuscript for intellectual content. RF acquisition of data, critical revision of manuscript for intellectual content. TL acquisition of data, critical revision of manuscript for intellectual content. VG acquisition of data, critical revision of manuscript for intellectual content. EL acquisition of data, critical revision of manuscript for intellectual content. AB acquisition of data, critical revision of manuscript for intellectual content. CM acquisition of data, critical revision of manuscript for intellectual content. NBR acquisition of data, critical revision of manuscript for intellectual content. GB acquisition of data, critical revision of manuscript for intellectual content. AB acquisition of data, analysis and interpretation of data, critical revision of manuscript for intellectual content. All authors read, revised and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement
All the raw data presented in this study are available to the corresponding author.
Rights and permissions
About this article
Cite this article
AME van der Beek, N., Nelson, I., Froissart, R. et al. A new case of SMA phenotype without epilepsy due to biallelic variants in ASAH1. Eur J Hum Genet 27, 337–339 (2019). https://doi.org/10.1038/s41431-018-0250-z
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41431-018-0250-z
This article is cited by
-
A novel intronic variant in the ASAH1 gene enhances aberrant splicing, causing spinal muscular atrophy with progressive myoclonic epilepsy
Italian Journal of Pediatrics (2025)
-
Genetic characterization of non-5q proximal spinal muscular atrophy in a French cohort: the place of whole exome sequencing
European Journal of Human Genetics (2024)
-
Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME): three new cases and review of the mutational spectrum
Italian Journal of Pediatrics (2023)
-
Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency
Communications Biology (2023)